Cargando…
Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study
Altered neuronal nitric oxide synthase function in Duchenne muscular dystrophy leads to impaired mitochondrial function which is thought to be one cause of muscle damage in this disease. The study tested if increased intramuscular nitric oxide concentration can improve mitochondrial energy metabolis...
Autores principales: | Hafner, Patricia, Bonati, Ulrike, Erne, Beat, Schmid, Maurice, Rubino, Daniela, Pohlman, Urs, Peters, Thomas, Rutz, Erich, Frank, Stephan, Neuhaus, Cornelia, Deuster, Stefanie, Gloor, Monika, Bieri, Oliver, Fischmann, Arne, Sinnreich, Michael, Gueven, Nuri, Fischer, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723144/ https://www.ncbi.nlm.nih.gov/pubmed/26799743 http://dx.doi.org/10.1371/journal.pone.0147634 |
Ejemplares similares
-
Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial
por: Hafner, Patricia, et al.
Publicado: (2016) -
Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
por: Hafner, Patricia, et al.
Publicado: (2019) -
Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
por: Kourakis, Stephanie, et al.
Publicado: (2020) -
Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
por: Kourakis, Stephanie, et al.
Publicado: (2021) -
Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial
por: Nagy, Sara, et al.
Publicado: (2019)